Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Rahim M Naimi; Mark Hvistendahl; Lotte H Enevoldsen; Jan L Madsen; Stefan Fuglsang; Steen Seier Poulsen; Hannelouise Kissow; Jens Pedersen; Nikolaj Nerup; Rikard Ambrus; Michael P Achiam; Lars B Svendsen; Jens Juul Holst; Bolette Hartmann; Svend H Hansen; Lars Ove Dragsted; Adam Steensberg; Ulrik Mouritzen; Mark B Hansen; Palle Bekker Jeppesen

doi:10.1016/S2468-1253(19)30077-9

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Rahim M Naimi, Mark Hvistendahl, Lotte H Enevoldsen, Jan L Madsen, Stefan Fuglsang, Steen Seier Poulsen, Hannelouise Kissow, Jens Pedersen, Nikolaj Nerup, Rikard Ambrus, Michael P Achiam, Lars B Svendsen, Jens Juul Holst, Bolette Hartmann, Svend H Hansen, Lars Ove Dragsted, Adam Steensberg, Ulrik Mouritzen, Mark B Hansen, Palle Bekker Jeppesen

15 Citations (Scopus)

Original language	English
Journal	The Lancet Gastroenterology and Hepatology
Volume	4
Issue number	5
Pages (from-to)	354-363
Number of pages	10
ISSN	2468-1253
DOIs	https://doi.org/10.1016/S2468-1253(19)30077-9
Publication status	Published - May 2019

Access to Document

10.1016/S2468-1253(19)30077-9

Cite this

Naimi, R. M., Hvistendahl, M., Enevoldsen, L. H., Madsen, J. L., Fuglsang, S., Poulsen, S. S., Kissow, H., Pedersen, J., Nerup, N., Ambrus, R., Achiam, M. P., Svendsen, L. B., Holst, J. J., Hartmann, B., Hansen, S. H., Dragsted, L. O., Steensberg, A., Mouritzen, U., Hansen, M. B., & Jeppesen, P. B. (2019). Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. The Lancet Gastroenterology and Hepatology, 4(5), 354-363. https://doi.org/10.1016/S2468-1253(19)30077-9

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. / Naimi, Rahim M; Hvistendahl, Mark; Enevoldsen, Lotte H et al.
In: The Lancet Gastroenterology and Hepatology, Vol. 4, No. 5, 05.2019, p. 354-363.

Research output: Contribution to journal › Journal article › Research › peer-review

Naimi, RM, Hvistendahl, M, Enevoldsen, LH, Madsen, JL, Fuglsang, S, Poulsen, SS , Kissow, H , Pedersen, J, Nerup, N, Ambrus, R, Achiam, MP, Svendsen, LB, Holst, JJ , Hartmann, B, Hansen, SH, Dragsted, LO, Steensberg, A, Mouritzen, U, Hansen, MB & Jeppesen, PB 2019, 'Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial', The Lancet Gastroenterology and Hepatology, vol. 4, no. 5, pp. 354-363. https://doi.org/10.1016/S2468-1253(19)30077-9

@article{0ac9442dc2224b1da81692fb12fa5d17,

title = "Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial",

author = "Naimi, {Rahim M} and Mark Hvistendahl and Enevoldsen, {Lotte H} and Madsen, {Jan L} and Stefan Fuglsang and Poulsen, {Steen Seier} and Hannelouise Kissow and Jens Pedersen and Nikolaj Nerup and Rikard Ambrus and Achiam, {Michael P} and Svendsen, {Lars B} and Holst, {Jens Juul} and Bolette Hartmann and Hansen, {Svend H} and Dragsted, {Lars Ove} and Adam Steensberg and Ulrik Mouritzen and Hansen, {Mark B} and Jeppesen, {Palle Bekker}",

year = "2019",

month = may,

doi = "10.1016/S2468-1253(19)30077-9",

language = "English",

volume = "4",

pages = "354--363",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Limited",

number = "5",

}

TY - JOUR

T1 - Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome

T2 - a randomised phase 2 trial

AU - Naimi, Rahim M

AU - Hvistendahl, Mark

AU - Enevoldsen, Lotte H

AU - Madsen, Jan L

AU - Fuglsang, Stefan

AU - Poulsen, Steen Seier

AU - Kissow, Hannelouise

AU - Pedersen, Jens

AU - Nerup, Nikolaj

AU - Ambrus, Rikard

AU - Achiam, Michael P

AU - Svendsen, Lars B

AU - Holst, Jens Juul

AU - Hartmann, Bolette

AU - Hansen, Svend H

AU - Dragsted, Lars Ove

AU - Steensberg, Adam

AU - Mouritzen, Ulrik

AU - Hansen, Mark B

AU - Jeppesen, Palle Bekker

PY - 2019/5

Y1 - 2019/5

U2 - 10.1016/S2468-1253(19)30077-9

DO - 10.1016/S2468-1253(19)30077-9

M3 - Journal article

C2 - 30880176

SN - 2468-1253

VL - 4

SP - 354

EP - 363

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 5

ER -

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Access to Document

Fingerprint

Cite this